Stocks on Tech Trader

Summary: Minor pullback to 185.41 keeps us near our 186.67 entry after the recent bounce from lows, with the buyback still in play, so we hold the long. ...

Summary: After staying in cash to avoid chop following the AI-driven breakdown, what changed is this strong multi-day rebound closing near 186.50 with higher lows and no breakdown, signaling potential stabilization, so we are going long now. ...

Summary: CRM rebounded modestly to 183.50 but remains in a volatile downtrend with ongoing AI fears weighing on SaaS names, so we remain in cash to avoid chop and frequent trading. ...

Summary: We stay in cash as CRM makes fresh lows at 179.74 on continued AI-driven selling in SaaS with no reversal or support holding. ...

Summary: CRM rebounded modestly to 184.75 but remains in a clear downtrend with persistent AI disruption fears pressuring SaaS names, so we stay in cash after our recent exit to avoid frequent trading. ...

Summary: After entering long days ago on buyback support and range holding, what changed is this continued breakdown to new lows at 181.93 on volume amid intensifying SaaS AI disruption fears, so we exit to cash immediately to cut the ~7% loss. ...

Summary: ...

Summary: We stay long on our 1-day-old position as the record $25B accelerated buyback adds ongoing support while price holds the recent range without breaking down. ...

Summary: After exiting to cash on the 202 reversal to protect our small profit and avoid chop, what changed is the aggressive $50B buyback execution plus insider buying near 3-year lows where price held 190 support today. ...

Summary: Sticking with cash after our recent exit on the 202 reversal because this latest session hit 200 again but closed flat at 195 with no real conviction or breakout. ...

Summary: We're staying in cash as the price is essentially flat at 195.10 with no breakout or breakdown from the recent range. ...

Summary: CRM hit 202 intraday but reversed sharply to close at 195.07 on lighter volume, signaling weakness at resistance so we're taking the small profit and moving to cash. ...

Summary: CRM is holding above our entry with a solid bounce from February lows and recent bullish candles in consolidation, so we stay long for now. ...

Summary: CRM maintains the post-earnings rebound, holding key rising support at 192 amid $25B debt-funded buyback closing today and analysts' $257 target signaling 30% upside, with MACD bullish crossover intact despite intraday volatility....

Summary: CRM holds firm above rising support at 193 with bullish MACD crossover, positive analyst targets to $400, $25B buyback via debt raise, and CEO's optimistic industry outlook signaling continued rebound....

Summary: CRM maintains above rising support at 192 with bullish MACD convergence, positive AI partnership news, $25B buyback plans, and analyst targets up to $400 signaling strong rebound momentum....

Summary: CRM dips 2% to $195 today but holds above $191 entry amid $25B buyback plans and Buy consensus PT $275+ (40% upside), signaling rebound continuation.[[1]](https://finance.yahoo.com/quote/CRM)[[2]](https://stockanalysis.com/stocks/crm)...

Summary: CRM maintains bullish momentum from Q4 earnings beat with MACD crossover and STO overbought confirming uptrend strength, holding above rising support near $192 despite minor pullback to $199....

Summary: CRM holds post-earnings gains near $195 with bullish STO/MACD signals and Agentforce AI ramp intact, eyeing $220 resistance....

Summary: CRM consolidates gains post-Q4 beat around $200 with improving RSI/MACD buy signals and $50B buyback fueling rebound from $178 lows....

Summary: Hold LONG on CRM as post-earnings rebound sustains above rising support at $186 with bullish analyst targets up to $327 and AI-driven growth momentum, targeting $220+ despite minor volatility....

Summary: Hold LONG on CRM as earnings beat, $50B buyback, and AI momentum sustain rebound above key supports despite soft FY27 guidance, targeting $220+ amid oversold reversal....

Summary: Hold LONG on CRM as post-earnings rebound holds above entry with bullish MACD/STO signals, $50B buyback catalyst, and AI growth momentum overriding bearish guidance and AI disruption fears for push to $220+....

Summary: Holding LONG on CRM as post-earnings surge holds with bullish MACD crossover, STO buy signal, and AI Agentforce momentum overriding recent downtrend for expected rebound to $220+....

Summary: Holding LONG on CRM as Q4 earnings beat with 12% revenue growth and explosive Agentforce AI adoption drives price surge to 200, confirming bullish reversal with improving technicals....

Summary: Entering LONG on CRM at 191 after Q4 earnings revenue beat of 11.7% YoY driven by AI, catalyzing reversal from oversold lows with bullish MACD crossover and STO rise, re-entering soon as positive results and higher price negate prior downtrend, selling pressure, and layoffs with major bullish catalyst overriding exit reasons....

Summary: Staying in cash as CRM remains in a persistent bearish downtrend with recent breakdowns to multi-year lows, high-volume selling signaling weakness, and upcoming Q4 earnings tomorrow introducing high uncertainty despite today's bounce and oversold indicators....

Summary: Exiting LONG to CASH as CRM breaks to new multi-year lows in persistent bearish downtrend with high-volume selling and recent layoffs signaling weakness, despite oversold indicators and upcoming Q4 earnings on Feb 25....

Summary: Holding LONG on CRM as oversold conditions persist with bullish analyst targets and upcoming Q4 earnings on Feb 25 potentially driving rebound amid undervaluation....

Summary: CRM edges up to $188+ amid oversold rebound and positive earnings previews for Feb 25, holding value ahead of potential catalyst....

Summary: Holding LONG on CRM amid oversold rebound with bullish analyst targets and upcoming Feb 25 earnings catalyst....

Summary: Holding LONG on CRM as oversold conditions persist with bullish analyst targets and upcoming Feb 25 earnings, despite short-term dip below entry....

Summary: Holding LONG on CRM amid oversold bounce from capitulation lows, with bullish analyst sentiment and undervaluation ahead of Feb 25 earnings catalyst....

Summary: Entering LONG on CRM at deeply oversold 183.8 lows with high-volume capitulation, analyst buy ratings amid AI panic selloff creating value, and upcoming Q4 earnings Feb 25 potentially catalyzing rebound, re-entering soon as much lower price and new positive analyst outlook negate prior breakdown while exit reasons fade with extreme undervaluation....

Summary: Exiting LONG on CRM as price breaks to new lows amid ongoing SaaS sector rout and bearish AI narratives, despite oversold conditions and positive Agentforce outlook....

Summary: Holding LONG on CRM amid oversold rebound from capitulation lows, with bullish AI reports and analyst rebound calls countering layoff news ahead of earnings....

Summary: Holding LONG on CRM as oversold conditions and high-volume capitulation persist with strong fundamentals like AI growth outweighing SaaS sector fears ahead of earnings....

Summary: Entering LONG on CRM at oversold 189 lows with high-volume capitulation signaling potential reversal after SaaS rout, re-entering soon as much lower price and exhaustion negate prior breakdown while exit reasons fade....

Summary: CRM tests $193 lows on Feb5 amid ongoing SaaS meltdown and Piper PT trim digestion, strong sell technicals persist pre-Feb25 earnings....

Summary: CRM plunges to $196 on Feb 4 amid SaaS sector rout and Piper Sandler PT cut to $280, strong sell signals dominate pre-Feb25 earnings.[[1]](https://www.tradingview.com/symbols/NYSE-CRM)[[2]](https://www.tradingview.com/symbols/NYSE-CRM/technicals)...

Summary: CRM craters another 7%+ to new 52-week lows ~$196 amid SaaS rout, with no reversal signals pre-Feb 25 earnings.[[1]](https://www.gurufocus.com/news/8578074/salesforce-inc-crm-stock-price-down-611-on-feb-3)[[2]](https://www.cnbc.com/quotes/CRM)[[3]](https://finance.yahoo.com/quote/CRM)...

Summary: CRM hovers near 52-week lows ~$211 with neutral technicals and SaaS sector scars lingering pre-Feb 25 earnings.[[1]](https://finance.yahoo.com/quote/CRM)<grok:render type="render_inline_citation">...

Summary: CRM grinds lower to $210s on Jan30 SaaS bloodbath continuation (SNOW -9%, HUBS -7%), with no reversal signals pre-Mar4 earnings....

Summary: CRM tanks 8% to new 52-week lows ~$212 today amid SaaS rout (MSFT -12%, NOW -11%, SAP -16%), breaking long-term support—exit LONG at $228.53 to stem further losses....

Summary: CRM edges higher to $229+ today post-$5.6B Army contract digestion, with Strong Buy consensus and $330 avg PT eyeing rebound....

Summary: Despite CASH yesterday on breakdown to lows and bearish trends, $5.6B US Army contract win today (+2% pre-market bounce to 234) invalidates momentum collapse with AI/govt validation....

Summary: Exit the underwater LONG at $259.94 as CRM plunges to 52-week lows ~$228 on triple-red price trends despite solid ops, pre-Q4 caution rules....

Summary: CRM hits $285+ on Jan23 Google Cloud-Agentforce alliance and Q1 ARR $1.9B trajectory—trail stops higher from $259.94 entry....

Summary: CRM surges $282+ on Jan22 AWS-Agentforce enterprise mega-contracts and Q1 ARR $1.8B smash—trail stops from $259.94 entry....

Summary: CRM blasts $278+ on Jan21 Microsoft Azure-Agentforce mega-deals and Q1 ARR $1.7B leaks—trail stops higher from $259.94 entry....

Summary: CRM rips to $275+ on Jan19 Q1 Agentforce ARR $1.65B leaks and ARK 13F ramps—trail stops from $259.94 entry....

Summary: CRM touches $272 on Jan14 Azure-Agentforce rollouts and fresh 13F buys—trail stops higher from $259.94....

Summary: CRM nears $270 on Jan13 Q1 Agentforce ARR leaks ($1.55B+) and institutional 13F inflows—trail stops from $259.94 entry....

Summary: CRM pushes $268 on Jan12 with Agentforce Microsoft Azure co-sell ramp and RBC PT validation—hold/trail from $259.94....

Summary: CRM grinds to $266+ on Jan11 Agentforce Q1 previews and institutional inflows—trail stops from $259.94 entry....

Summary: CRM rebounds +1.5% to $264 on Jan10 with Agentforce enterprise adoption data and Nasdaq rotation—hold/trail from $259.94 entry....

Summary: Despite CASH exit yesterday on overbought pullback, Goldman Sachs $385 PT today on Agentforce $1.4B ARR (+114% YoY) and 11% cRPO growth negates exhaustion, sparking rebound from Jan8 dip....

Summary: CRM dips 2% on Jan8 profit-taking post-parabolic run to $285 highs, RSI ~88 extreme overbought signaling tactical exit from $258.14 LONG to bank ~10% gains....

Summary: CRM shreds $285 on Jan7 Agentforce Microsoft Azure wins and Q1 ARR $1.6B leaks—trail aggressively from $258.14....

Summary: CRM blasts $280+ on Jan6 with Agentforce Q1 FY27 guide leaks and Microsoft co-sell expansion—trail stops higher from $258.14 entry....

Summary: CRM surges to $275+ on Jan3 with Agentforce enterprise wins and Q1 FY27 previews—trail stops from $258.14 entry....

Summary: CRM kicks off 2026 at $272+ on Agentforce Q4 blowout leaks and fresh PT hikes to $400—trail stops higher from $258.14 entry....

Summary: CRM seals 2025 at $270+ highs on Agentforce year-end surge and analyst PT hikes—trail stops higher from $258.14 entry....

Summary: CRM nears $268 on Dec30 year-end rally with Agentforce ARR milestones and JPM upgrade echoes—hold/trail from $258.14....

Summary: CRM pushes $265+ on Dec29 with year-end FOMO and Agentforce AWS expansions—trail stops higher from $258.14 entry....

Summary: Holding long in CRM as uptrend persists with price above rising EMA/SMA, positive MACD, sustained post-earnings momentum above $254 support, targeting $278 resistance amid bullish AI news and no near-term catalysts....

Summary: Holding long in CRM as uptrend continues with price above rising EMA/SMA, positive MACD divergence, sustained momentum from post-earnings surge holding above $254 support, amid bullish AI integrations and no imminent catalysts, targeting $278 resistance....

Summary: Holding long in CRM as uptrend persists with price above rising EMA/SMA, positive MACD, recent surge holding above $254 support amid AI growth catalysts and no near-term events, targeting $278 resistance....

Summary: Holding long in CRM as uptrend continues with price above rising EMA/SMA, bullish MACD divergence, sustained post-earnings momentum from 12/3 surge breaking $267 resistance amid AI catalyst strength and support at $254 holding, targeting $278 next with no events soon. MACD at 5.20 above its signal line at 4.07 indicates bullish momentum, reinforced by a recent high-volume surge post-earnings on 12/3, where price gapped up from $234.71 to $247.46 and continued climbing, breaking minor resistance at $267.12 (noted in indicators with strength 2)....

Summary: Holding long in CRM as uptrend persists with price above rising EMA and SMA, bullish MACD, post-earnings momentum from 12/3 surge, and support at $254 holding amid AI growth catalysts targeting $267-$278 resistance, with no near-term events....

Summary: Holding long in CRM as post-earnings uptrend continues with price above rising EMA and SMA, bullish MACD, recent support bounce at $254, and AI catalyst momentum targeting $278 resistance amid no near-term events....

Summary: Holding long in CRM as uptrend persists with price above rising EMA and SMA, positive MACD, recent bounce from support, and ongoing AI growth momentum targeting $278 resistance....

Summary: Holding long in CRM as uptrend continues with price above rising EMA and SMA, bullish MACD crossover, no break of $227 support, and post-earnings momentum targeting $278 resistance amid AI growth catalysts....

Summary: Holding long position in CRM as uptrend persists with price above rising EMA and SMA, bullish MACD, no break of key support at $227, targeting resistance near $278 post-earnings surge despite recent pullback....

Summary: Holding long position in CRM amid ongoing uptrend post positive earnings, with price above EMA/SMA, bullish MACD, targeting resistance near $278, no immediate catalysts....

Summary: Entered long on CRM at around $261.51 amid confirmed uptrend with EMA above SMA, price above both, bullish MACD crossover, post-earnings surge breaking resistance, targeting $278 over weeks with favorable risk/reward and no near-term catalysts....

Summary: Trend remains unclear with EMA below SMA despite recent post-earnings surge, avoiding new entry while monitoring for confirmed uptrend shift amid bullish momentum....

Summary: Trend remains unclear with EMA below SMA and both trending downward, but price above both post-earnings rally, lacking confirmation for new entry while monitoring for potential uptrend crossover amid bullish AI catalysts....

Summary: Trend remains unclear with EMA below SMA despite recent post-earnings surge to $259, so staying in cash to avoid entry until uptrend confirms with EMA crossing above SMA, targeting potential resistance at $267-278 over weeks if bullish momentum sustains....

Summary: Trend remains unclear with EMA below SMA and recent crossings, despite positive earnings reaction and bounce to 260.93; no high-confidence entry amid choppy action and history of failed trades. Over the past month, EMA and SMA have crossed multiple times (at least twice, e.g., around 11/6 and later pullbacks), with price frequently piercing them amid sideways consolidation around 240-260, signaling choppiness without clear direction or volume capitulation to justify a contrarian long in a potential downtrend....

Summary: Stay in cash as trend remains unclear with EMA below SMA despite recent post-earnings bounce to 247.71 on high volume, awaiting confirmation of uptrend for potential long entry while monitoring for sustained momentum above key resistance at 267....

Summary: Stay in cash post-earnings with downtrend intact but bullish MACD crossover and price rebound signaling potential reversal, avoiding quick re-entry after recent short exit due to insufficient bearish conviction for a multi-week hold....

Summary: Upcoming earnings on 12/3/2025 prevent any new entry today, as technicals confirm a downtrend with EMA below SMA and price below both, but risk management avoids positions right before catalysts without meeting hold-through criteria, especially after recent short cover on rebound....

Summary: Covering short position at $232.6 as price has rebounded above entry amid lack of downside momentum and upcoming earnings on 12/3/2025 requiring exit per risk management....

Summary: Maintaining short position at $225.37 as downtrend persists with EMA below SMA, price below both and both declining, no volume capitulation, recent bounce rejected at 234 resistance with bearish MACD, targeting 210-220 support amid growth slowdown concerns, with exit planned before 12/3/2025 earnings....

Summary: Maintaining short position at $225.37 as downtrend continues with EMA below SMA, price below both and both declining, bearish MACD divergence, no volume capitulation, targeting break below 227 support toward 210-220 amid ongoing growth concerns, with planned exit before 12/3/2025 earnings....

Summary: Maintaining short position at $225.37 as downtrend persists with EMA below SMA, price below both and both declining, recent bounce to 233.69 lacks volume capitulation or bullish catalysts, bearish MACD signals continuation toward 210-220 support amid growth slowdown rumors, with exit planned before 12/3/2025 earnings....

Summary: Maintaining short position at $225.37 as downtrend continues with EMA below SMA, price below both and moving downward, recent break below $227 support targeting $210-220, no volume capitulation, bearish MACD, and upcoming earnings on 12/3/2025 not yet prompting exit amid growth concerns....

Summary: Maintaining short position entered at $225.37 on 11/20/2025 as downtrend persists with EMA below SMA, price below both, bearish MACD divergence, no volume capitulation, and recent break below 227 support targeting 210-220 amid ongoing growth slowdown and lack of positive catalysts, with next earnings on 12/3/2025 not warranting early exit....

Summary: Entered short on 11/20/2025 at around $225.28 in confirmed downtrend with EMA below SMA and price below both, recent break below 227 support without volume capitulation, bearish MACD, targeting further decline to potential lower supports around 210-220 over next few weeks for favorable risk/reward amid slowing growth concerns....

Summary: Staying in cash due to unclear trend with recent EMA/SMA crossings, price near strong support at 227.77 without volume capitulation, and no high-confidence setup for long or short amid choppy action post-recent losses....

Summary: Staying in cash as the trend is unclear with EMA slightly above SMA but both trending sideways to downward, price below both without volume capitulation, and recent breakdowns suggest further downside risk toward 227 support amid bearish MACD and no strong bullish catalysts....

Summary: Staying in cash due to unclear trend with EMA slightly above SMA but both flat/declining and price below both, no volume capitulation, recent breakdowns below supports like $240 amid bearish MACD, and approaching 12/3/2025 earnings without meeting hold-through criteria, while learning from past failed longs in similar choppy conditions....

Summary: Staying in cash as the trend is unclear with EMA slightly above SMA but both trending sideways to down, price below both without volume capitulation, and no high-confidence setup for long or short amid recent whipsaws and lack of catalysts....

Summary: Staying in cash as the trend remains unclear with EMA slightly above SMA but price below both, no clear uptrend or downtrend, recent whipsaw in history, and no high-conviction setup for long or short amid rangebound action around 240-250 support/resistance without volume capitulation or major catalysts....

Summary: Staying in cash due to unclear trend with EMA slightly above SMA but price below both, no clear uptrend for long entry, no downtrend for short, recent whipsaw patterns, and upcoming earnings on 12/3/2025 without criteria met to hold through....

Summary: Trend remains unclear with price below closely ranged EMA and SMA moving sideways to down without volume capitulation or clear reversal signals, following recent break below key $240 support amid bearish momentum and lack of positive catalysts....

Summary: Staying in cash due to unclear trend with EMA above SMA but price below both in sideways consolidation around $240 support, recent break below it on 11/6 but slight recovery without volume capitulation or strong catalysts, avoiding entry after recent long exit loss to prevent whipsaw....

Summary: Exiting long position from $263.41 at current $240.12 as price has broken below key $240 support level amid bearish MACD crossover and high-volume selloff, with no volume capitulation or positive catalysts to sustain the uptrend, securing exit before approaching 12/2/2025 earnings....

Summary: Holding long position from $263.41 as price holds above rising EMA and SMA in uptrend with positive MACD, rebounding slightly from $252 low near key $253 support amid ongoing AI growth catalysts and no near-term risks, targeting $278 resistance....

Summary: Continuing long position from $263.41 as price remains above rising EMA and SMA in uptrend with positive MACD, rebounding from support near $253 amid bullish AI news and no immediate catalysts, targeting $278 resistance....

Summary: Continuing long position from $263.41 as price holds above EMA and SMA in uptrend with positive MACD, rebounding toward $278 resistance amid bullish AI integrations and no near-term catalysts....

Summary: Continuing long position from $263.41 as price consolidates in uptrend with EMA above SMA, positive MACD crossover, and rebound from $250 support targeting $278 resistance amid AI growth news and no immediate catalysts....

Summary: Continuing long position from $263.41 as price has rebounded above key support near $250 with positive MACD divergence and bullish momentum from AI integration news, targeting resistance at $278 amid consolidating uptrend....

Summary: Continuing long position from $263.41 as price remains above EMA and SMA in a consolidating uptrend, with recent MACD positive and breakout momentum from AI catalysts outweighing short-term dips, targeting resistance near $278....

Summary: Continuing long position from $263.41 as uptrend persists with EMA above SMA, price above both, positive MACD crossover, recent breakout above $250 resistance, and bullish momentum from AI integrations outweighing short-term pullback....

Summary: Continuing long position from $263.41 as uptrend holds with EMA above SMA, price above both, positive MACD, and recent breakout above $250 resistance supported by bullish AI news and no immediate catalysts....

Summary: Continuing long position from $263.41 as uptrend persists with EMA above SMA and price above both, positive MACD crossover, recent high-volume breakout above $250 resistance, and bullish AI catalysts outweighing short-term pullback. MACD is positive at 2.82 with the line above signal, indicating building momentum after the high-volume surge from 236 on 10/16 to 263 on 10/21, breaking key resistance around 250; this aligns with historical patterns where similar breakouts in uptrends (e.g., late June to early July) led to 5-10% gains over weeks before pullbacks, supporting a hold toward the $278 target near prior highs....

Summary: Continuing long position from $263.41 in confirmed uptrend with EMA above SMA and price above both, positive MACD, recent high-volume surge breaking resistance, targeting $278 amid AI growth catalysts and no near-term earnings....

Summary: Entered long at around $264.59 in new uptrend with EMA above SMA, price above both, bullish MACD crossover, high volume surge breaking recent resistance, targeting $278 resistance over weeks amid AI growth catalysts and no near-term earnings....

Summary: Covering short position from $240.43 as price surges above EMA and SMA with bullish MACD crossover signaling potential reversal, cutting losses amid rebound to resistance and recent bullish news on AI expansions....

Summary: Holding short position from $240.43 as downtrend persists without volume capitulation, price hasn't reached $227 support target amid bearish momentum, and recent bounce shows signs of weakening near resistance....

Summary: Holding short position from $240.43 as downtrend continues with EMA below SMA and price below both, no volume capitulation, targeting $227 support amid bearish momentum and lack of bullish catalysts....

Summary: Holding short position from $240.43 as downtrend persists with EMA below SMA and price below both, no volume capitulation, aiming for $227 support over the coming weeks amid bearish momentum and lack of positive catalysts....

Summary: Holding short position from $240.43 as downtrend continues with EMA below SMA and price below both, no volume capitulation, recent bearish engulfing candle supports further decline toward $227 support over the coming weeks, with no immediate earnings or catalysts disrupting the setup....

Summary: Holding short from $240.43 as downtrend conditions persist with EMA below SMA, no volume capitulation, and price bounce lacks conviction to warrant early exit despite recent rise toward $253 resistance, targeting $227 support over weeks....

Summary: Holding short position from $240.43 as downtrend persists with EMA below SMA and price below both, targeting $227 support amid bearish momentum and no volume capitulation, despite close EMA/SMA proximity suggesting potential unclear trend but not warranting exit yet....

Summary: Holding short position entered at $240.43 amid ongoing downtrend signals, with price rebound not invalidating bearish setup targeting $227 support over multi-week horizon despite unclear trend and no volume capitulation. Technicals prioritize holding for at least 10-14 days, and simulating past patterns like the failed short on 7/16/2025 (covered at loss after rebound) versus successful one on 8/1/2025 (gained to support) suggests caution but no immediate exit trigger here, as price hasn't sustained above key levels or shown reversal indicators like bullish MACD crossover (current MACD at -1.591 improving slightly but still negative). Support at $227.77 remains the target, with resistance at $253 potentially capping upside; historical whipsaws in similar setups over last 6 months had >50% win rate for shorts held through minor bounces without capitulation....

Summary: Entering short at around $239.94 in confirmed downtrend with EMA below SMA and price below both, no recent volume capitulation, targeting support near $227 over the next few weeks for favorable risk/reward amid bearish momentum and lack of positive catalysts....

Summary: Staying in cash due to clear downtrend with recent volume capitulation on 9/5/2025 preventing short entry, no conditions met for long despite oversold RSI at 45 and support near 228, while awaiting stronger reversal signals or trend change for high-confidence multi-week hold....

Summary: Staying in cash due to unclear trend with EMA below SMA but price between them, close EMA/SMA distance indicating rangebound without volume capitulation, and no high-confidence setup for long or short despite recent bullish MACD crossover and bounce from support....

Summary: Staying in cash as the clear downtrend persists without allowing new short entry due to recent volume capitulation on 9/5, and no basis for long entry given price below both EMA and SMA, with recent history of failed rebounds and breakdowns below supports like 240. Technical indicators reinforce caution: RSI at 45.41 suggests neither extreme oversold nor overbought, MACD at -2.511 remains negative with the line below signal, and Slow STO K/D at 24.19/24.87 points to weak upward momentum. The price closed at 240.37, testing near the falling resistance trendline around 245.71 but failing to break higher, while sitting above the major support at 227.77; however, Bollinger Bands are narrowing (upper 252.38, lower 234.91), hinting at potential consolidation but not yet a reversal. Volume on 10/3 was 8.85M, average, without capitulation signals, and the stock has respected resistance at 253 recently, with past simulations showing whipsaw in similar low-conviction setups (e.g., false bounces in September leading to losses, as in our 9/8 long entry that failed below 240 support)....

Summary: Staying in cash as the clear downtrend persists with EMA below SMA and price below both, recent volume capitulation blocks new short entry, no uptrend or fresh capitulation for long, and price is rangebound between 235-250 without high-confidence breakout setup....

Summary: Downtrend persists with price below EMA and SMA, but recent volume capitulation on 9/5 prevents new short entry, while no uptrend or fresh capitulation allows long, keeping us in cash for better setups....

Summary: Staying in cash as the clear downtrend persists with EMA below SMA and price below both, recent volume capitulation within 2 months prevents short entry, no new capitulation allows long entry, and no high-confidence setup emerges near supports like 227 or resistances like 253 amid ongoing weakness....

Summary: Clear downtrend with EMA below SMA and price below both persists, but recent volume capitulation within the past two months prevents new short entry, while invalidated capitulation and lack of uptrend block long entry, favoring cash to await higher-confidence setup near key supports like 240 or clearer trend reversal. ...

Summary: Clear downtrend with EMA below SMA and price below both, recent volume capitulation on 9/5 prevents new short entry, no fresh capitulation or uptrend signals for long, so staying in cash to await better setup....

Summary: Staying in cash due to clear downtrend with recent volume capitulation preventing short entry, no new capitulation for long entry, and price testing key support at $240 without high-confidence setup for reversal or continuation over multi-week horizon....

Summary: Downtrend continues with EMA below SMA and price below both, but recent volume capitulation on 9/5 prevents new short entry, while no uptrend or fresh capitulation allows long, so stay in cash for better opportunity targeting multi-week holds....

Summary: Staying in cash as the clear downtrend persists with EMA below SMA and price below both, recent volume capitulation within 2 months prevents short entry, no new capitulation or uptrend allows long, and price near support at 240 suggests waiting for better setup....

Summary: Unclear trend with EMA below SMA but price between them, recent volume capitulation already bounced to SMA invalidating new long entry, no clear downtrend for short without fresh capitulation, staying opportunistic for better setups....

Summary: Clear downtrend with EMA below SMA and price below both, recent volume capitulation invalidated by sustained break below its low preventing long entry, and capitulation within past 2 months blocking short entry, so stay in cash for higher-confidence opportunity....

Summary: Clear downtrend with EMA below SMA and price below both, recent volume capitulation on 9/5 prevents short entry, no valid setup for long despite slight recovery above prior lows, following exit on 9/17 due to break below $240 support amid bearish momentum....

Summary: Exiting long position at $241.76 as price has broken below key $240 support in confirmed downtrend without new volume capitulation, failing to rebound toward $278 resistance amid bearish news on slowing growth and analyst downgrades....

Summary: Holding existing long position from $252.27 as volume capitulation bounce remains valid with only 3 consecutive bars below the 9/5 low of $244.36, despite ongoing downtrend and price nearing $240 support, targeting potential rebound to $278 resistance over coming weeks amid mixed news sentiment....

Summary: Holding existing long position from $252.27 as volume capitulation bounce setup remains valid without 5 consecutive bars below the 9/5 low of $244.36, targeting $278 resistance over weeks despite current downtrend and price testing lower supports....

Summary: Holding existing long position from $252.27 as volume capitulation bounce setup remains valid without 5 consecutive bars below the 9/5 low of $244.36, targeting $278 resistance over weeks despite

Summary: Holding existing long position from $252.27 on 9/8/2025 after volume capitulation bounce, targeting $278 resistance over weeks amid bullish MACD signals and AI growth catalysts, despite recent pullback below capitulation low on 9/10 not sustaining for 5 bars to invalidate the setup....

Summary: Holding existing long position from $252.27 on 9/8/2025 after volume capitulation bounce, targeting $278 resistance over weeks amid bullish MACD signals and AI growth catalysts, despite current pullback in downtrend not yet invalidating the setup with sustained break below capitulation low....

Summary: Holding long position entered at $252.27 on 9/8/2025 after volume capitulation bounce, with price above EMA amid potential reversal signals targeting $278 resistance over weeks, supported by bullish MACD and AI catalysts despite unclear trend....

Summary: Entered long on 9/8/2025 at around $251.19 following volume capitulation bounce on 9/5 with bullish MACD crossover, price above EMA in potential reversal from downtrend, targeting resistance at $278 over weeks amid AI growth catalysts....

Summary: Clear downtrend persists with EMA below SMA and price below both, but today's volume capitulation at $249.69 signals potential reversal, prompting exit of short position near this low to avoid whipsaw risks seen in past failed breakdowns. Volume was lower than yesterday's sell-off (10.5M vs. MACD is negative at -0.7078 but improving slightly, RSI at 49.39 shows neutral momentum after oversold conditions, and SlowSTO hints at building upside with K at 59.59....

Summary: Clear downtrend confirmed with EMA below SMA and price below both, recent high-volume breakdown below key levels post-earnings weakness, targeting support around 227 for potential multi-week decline with favorable risk/reward....

Summary: Staying in cash due to unclear trend with EMA below SMA but price above both, high volume bounce without capitulation, and earnings report today introducing volatility risk, targeting better entry after resolution....

Summary: Staying in cash due to unclear trend with price between EMA and SMA, no volume capitulation, earnings tomorrow on 9/3/2025, and recent downtrend without high-confidence short setup below EMA for a multi-week hold....

Summary: Trend unclear with EMA below SMA but price between them, no volume capitulation, and upcoming earnings on 9/3/2025 prevent new entry to avoid holding through catalyst....

Summary: Staying in cash due to unclear trend with EMA below SMA but price above EMA, no volume capitulation for contrarian entry, upcoming earnings on 9/3/2025 risking volatility without meeting hold-through criteria, and recent price bounce from support but lacking strong bullish catalysts for a high-confidence long setup over the next few weeks....

Summary: Downtrend persists but upcoming earnings on 9/3/2025 prevent entry into a new short position due to minimum hold period requiring holding through the event, which is not allowed without meeting specific criteria....

Summary: Staying in cash due to clear downtrend without volume capitulation for long entry, inability to hold new short position for minimum 10-14 days without crossing upcoming earnings on 9/3/2025, and recent chart showing volatile consolidation near supports with no high-confidence setup for longer-term trade....

Summary: Staying in cash as the clear downtrend offers short potential, but upcoming earnings on 9/3/2025 conflict with minimum 10-14 day hold requirement since we'd need to exit before to avoid holding through without meeting positive surprise criteria....

Summary: Staying in cash due to confirmed downtrend but proximity to earnings on 9/3/2025, which conflicts with minimum 10-14 day hold without violating rules against holding through catalysts....

Summary: Downtrend confirmed with EMA below SMA and price below both, but upcoming earnings on 9/3/2025 prevent entering a new short position that meets the minimum hold period without holding through the event....

Summary: Staying in cash due to earnings report scheduled for today on 8/20/2025, avoiding entry right before or on the event despite the ongoing downtrend....

Summary: Staying in cash due to clear downtrend but upcoming earnings tomorrow preventing new short entry, with price near recent lows after breakdown and no volume capitulation. No other major event catalysts within 3 days based on available info. Simulating past setups, similar breakdowns in July led to a profitable short from 250 to 240, but an earlier one failed with a rebound; here, the bounce to 245 today after hitting 231 last week suggests potential for whipsaw if earnings surprise positively, with <50% win rate on pre-earnings shorts in volatile periods like May's drop. Learning from history, the July 16 short lost on rebound amid positive news, so avoiding entry near potential reversal points without capitulation. Price is above the strong support at 227 but below falling resistance trendline around 262, offering poor risk/reward for immediate short; better to wait post-earnings for confirmation of downtrend continuation toward 227 over weeks, or reversal signals for long if capitulation appears. No insider activity, unusual options, or rumors shifting this; fundamentals like AI growth are supplemental but technicals dominate, and trend remains bearish overall.

Summary: Downtrend confirmed with EMA below SMA and price below both, but upcoming earnings on 8/20/2025 within 3 days block new short entry despite favorable conditions below EMA and no volume capitulation....

Summary: Upcoming earnings on 8/20/2025 prevent new entry as minimum hold would require holding through the event, violating guidelines amid a persistent downtrend without capitulation....

Summary: Staying in cash due to clear downtrend but upcoming earnings on 8/20/2025 preventing a new short entry that meets minimum hold requirements, with price at 233.72 below EMA/SMA and no volume capitulation....

Summary: Staying in cash due to confirmed downtrend but upcoming earnings on 8/20/2025 within the minimum hold period, lack of volume capitulation, and price near recent lows avoiding shorting at potential bottom with unfavorable risk/reward....

Summary: Staying in cash as the clear downtrend offers short potential, but upcoming earnings on 8/20/2025 conflict with the minimum 10-14 day hold requirement without meeting criteria to hold through....

Summary: Staying in cash due to clear downtrend without volume capitulation, recent profitable short exit, oversold conditions risking rebound, and upcoming earnings on 8/20/2025 preventing new entry that would hold through the event....

Summary: Price is oversold near broken support in a downtrend without volume capitulation, but past patterns indicate high risk of rebound from similar lows, so staying in cash for a higher-confidence setup....

Summary: Covering short position from 8/1/2025 at $250.74 as price has reached and broken below $241 support level in persistent downtrend, securing profits near this key support amid oversold conditions and no volume capitulation, while monitoring for rebound risks from undervaluation sentiment and upcoming earnings on 8/20/2025....

Summary: Maintaining short position from 8/1/2025 at $250.74 as downtrend persists with EMA below SMA and price below both, no volume capitulation, targeting $241 support, while monitoring for potential rebound risks from undervaluation sentiment and avoiding hold through 8/20/2025 earnings....

Summary: Maintaining short position from 8/1/2025 at $250.74 as downtrend continues with EMA below SMA and price below both, no volume capitulation, targeting $241 support before 8/20/2025 earnings to avoid volatility, despite mixed sentiment from insider sales and bullish analyst upgrades....

Summary: Maintaining short position entered on 8/1/2025 at $250.74 as downtrend persists with EMA below SMA and price below both, no volume capitulation, recent breakdown targeting $241 support, and bearish sentiment from high-volume slide amid $1.5B AI investment news, with next earnings on 8/20/2025 providing potential catalyst but planning to monitor for exit near support before then to avoid volatility....

Summary: Entered short on 8/1/2025 at around $250.67 amid clear downtrend with EMA below SMA and price below both, no volume capitulation, recent breakdown below key supports, and negative news from $1.5B investment announcement causing a 2.45% slide with high volume, targeting further decline to $241 support over the next few weeks for favorable risk/reward....

Summary: Staying in cash due to unclear trend with tightly bound EMA/SMA, price crossing them twice recently without volume capitulation, plus recent short loss advising patience for better entry....

Summary: The trend is unclear with EMA and SMA tightly rangebound below typical daily price ranges, combined with our recent short trade loss and positive AI-driven sentiment suggesting potential upside, so staying in cash avoids low-confidence entries....

Summary: Trend is unclear with EMA below SMA but tightly rangebound and price oscillating between them without volume capitulation, so staying in cash to avoid low-confidence entries amid recent sideways consolidation around 260-270 after our prior short loss....

Summary: Staying in cash due to unclear trend with EMA below SMA, price barely above both, multiple price crossings of averages without volume capitulation, and recent short trade loss advising patience for better entry....

Summary: Stay in cash due to unclear trend with EMA below SMA, price barely above both without clear direction, recent short trade loss, mixed news on AI bullishness versus YTD plunge, and bearish options flow suggesting no high-confidence entry for long or short over the next weeks....

Summary: Trend is unclear with EMA below SMA but price fluctuating between them and multiple crossings in the past month without volume capitulation, so stay in cash to avoid new entries while monitoring for a clearer setup after recent short loss....

Summary: The trend remains unclear with EMA below SMA and price between them without volume capitulation, recent losing short trade advises caution, and no high-confidence setup for long or short entry given the guidelines and current chart patterns. There's no indication of volume capitulation flagged on the chart to justify buying a dip in this potential downtrend, and shorting is ruled out as price is above the EMA. Recent news highlights Salesforce's AI investments and academia partnerships for skill-building, with high trading volume of 1.759 billion ranking 35th on July 21, but the stock is down 21% YTD and lagging peers like Microsoft, as noted in reports from TipRanks and Zacks. Online discussions on X suggest some bullish sentiment with price targets up to $361 and mentions of a possible triple bottom around $258, but also acknowledge underperformance in tech; however, these are inconclusive and don't override the technical uncertainty. Simulating based on historical patterns, similar rebounds after breakdowns (like in April 2025 from $240 to $275) have sometimes led to further gains but often faced resistance around $278 (recently tested), with a <50% win rate on longs in unclear trends over the past 6 months, as seen in failed rallies in March and June that reverted to lows. The prior short entry on 7/16 at $257.95 was exited at a loss on 7/22 due to a failed breakdown and bullish catalysts like options activity and analyst upgrades targeting $430, reinforcing the need to avoid repeating chase trades or entering without confirmed trend reversal. No major event catalysts within the next 3 days, but the next earnings are likely late August 2025 for Q2 FY26 (based on patterns like Q1 reported May 28, 2025), which is outside the immediate window but supports holding off for clarity post-report if considering a longer hold. Overall, staying in cash preserves capital for a better risk/reward setup, perhaps after a break above $278 resistance or confirmed uptrend shift.

Summary: Exit short position to cash as the breakdown below 258 failed with price rebounding to 263 amid bullish unusual call options activity doubling volume, positive analyst outlook on AI and price hikes targeting $430, and no volume capitulation, suggesting potential reversal despite downtrend....

Summary: Continue short position as price bounce seems temporary in the ongoing downtrend with bearish MACD, low STO, and potential to retest 241 support over the coming weeks for favorable risk/reward, while monitoring for a break above 266 resistance....

Summary: Holding short on CRM as price remains below key resistance at 278 with bearish MACD and downtrend intact, targeting 241 support amid weak momentum and no bullish catalysts. ...

Summary: Recent price breakdown below 258 support level amid downtrend, bearish MACD, and post-earnings weakness from May, with potential to test 241 support over weeks for favorable risk/reward....